)
Visual
test
aTyr Pharma
aTyr Pharma (ATYR) investor relations material
aTyr Pharma Proxy filing summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Proxy filing summary26 Mar, 2026
Executive summary
Annual Meeting scheduled for May 11, 2026, at 9:00 a.m. Pacific Time at company headquarters.
Proxy materials, annual report, and meeting directions are available online, with options to request paper or email copies.
Stockholders are invited to attend and participate in voting on key proposals.
Voting matters and shareholder proposals
Election of three Class II directors to serve until the 2029 annual meeting or until successors are elected.
Ratification of Ernst & Young LLP as independent auditor for fiscal year ending December 31, 2026.
Advisory vote to approve executive compensation.
Approval of an amendment to the 2015 Stock Option and Incentive Plan.
Approval of an amendment to increase authorized common stock from 170,000,000 to 340,000,000 shares.
Board of directors and corporate governance
Board recommends voting in favor of all director nominees and proposals.
Nominees for Class II directors: Eric Benevich, Timothy P. Coughlin, Jane A. Gross, Ph.D.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from aTyr Pharma
- Shareholders to vote on key governance, compensation, and capital structure changes at annual meeting.ATYR
Proxy filing26 Mar 2026 - Proxy covers director elections, auditor ratification, compensation, and capital structure changes.ATYRProxy Filing12 Mar 2026
- Efzofitimod shows durable quality of life gains and is reshaping sarcoidosis treatment practices.ATYRLeerink Global Healthcare Conference 202611 Mar 2026
- 2025 net loss reached $74.1M; FDA to review efzofitimod Phase 3 results in April 2026.ATYRQ4 20255 Mar 2026
- First-in-class ILD therapy nears phase 3 completion, with robust clinical and pipeline progress.ATYRJefferies Global Healthcare Conference1 Feb 2026
- Late-stage tRNA synthetase drug shows promise in rare lung diseases, with major data due next year.ATYRH.C. Wainwright 26th Annual Global Investment Conference20 Jan 2026
- Efzofitimod shows promise in phase III sarcoidosis, with robust pipeline and financial strength.ATYR2024 Cantor Fitzgerald Global Healthcare Conference20 Jan 2026
- Efzofitimod advances as a potential first-in-class therapy for sarcoidosis, with phase III data due in 2025.ATYR17th Annual LD Micro Main Event Conference18 Jan 2026
- Efzofitimod's phase III trial targets steroid-free treatment for sarcoidosis, with promising early results.ATYRStifel 2024 Healthcare Conference13 Jan 2026
Next aTyr Pharma earnings date
Q1 20261 May, 2026
aTyr Pharma
Next aTyr Pharma earnings date
Q1 20261 May, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Explore our global coverage